Trazodone Hydrochloride
- Product NDC
- 60505-4089
- Requested package NDC
- 60505-4089-3
- 11-digit product format
- 605054089
- Labeler code
- 60505
- Product ID
- 60505-4089_a014d870-1a59-8026-826e-7acd952b4478
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Trazodone Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Apotex Corp
- Application
- ANDA071196
- Marketing category
- ANDA
- Marketing start
- 2014-12-31
- Marketing end
- 0000-00-00
- Substance
- TRAZODONE HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Serotonin Reuptake Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 60505-4089 | 60505-4089-3 | D | Discontinued by firm | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A071196-001 | TRAZODONE HYDROCHLORIDE | TRAZODONE HYDROCHLORIDE | 100MG | TABLET / ORAL | AB | RS | 1987-03-25 |
| A071196-002 | TRAZODONE HYDROCHLORIDE | TRAZODONE HYDROCHLORIDE | 150MG | TABLET / ORAL | AB | 1999-04-26 | |
| A071196-003 | TRAZODONE HYDROCHLORIDE | TRAZODONE HYDROCHLORIDE | 300MG | TABLET / ORAL | AB | 1999-04-26 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A071196-001 | AB |
| A071196-002 | AB |
| A071196-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A071196-001 | TRAZODONE HYDROCHLORIDE | 100MG | TABLET / ORAL | AB | RS | 1987-03-25 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A071196-002 | TRAZODONE HYDROCHLORIDE | 150MG | TABLET / ORAL | AB | 1999-04-26 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A071196-003 | TRAZODONE HYDROCHLORIDE | 300MG | TABLET / ORAL | AB | 1999-04-26 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A071196-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A071196-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A071196-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Trazodone Hydrochloride | TRAZODONE HYDROCHLORIDE | REMEDYREPACK INC. | dc1f347e-1acb-4c06-b36e-f15fecb7ac93 | 2026-04-08 | Boxed warning, Warnings, Adverse reactions | 071196 ANDA071196 |
| Trazodone Hydrochloride | TRAZODONE HYDROCHLORIDE | Apotex Corp | 71961ab1-951d-1493-f76c-2ff25cca2a85 | 2026-03-24 | Boxed warning, Warnings, Adverse reactions | 071196 ANDA071196 60505-4089-3 60505-4089 60505408903 |
| Trazodone Hydrochloride | TRAZODONE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 5d22a06c-9cb8-4b49-8d67-769d181ad70c | 2021-03-10 | Boxed warning, Warnings, Adverse reactions | 071196 ANDA071196 |
| Trazodone Hydrochloride | TRAZODONE HYDROCHLORIDE | Teva Pharmaceuticals USA, Inc. | 9c4da6ad-d4d1-4e8c-918d-8ac48512a93f | 2020-06-30 | Boxed warning, Warnings, Adverse reactions | 071196 ANDA071196 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ac7a3d9b-58c0-4ffc-a3eb-ed863453525e | Product name | 1 | 20250730 |
| b2f15d64-48ea-ba98-af5c-91f410667b31 | Product name | 5 | 20250314 |
| d8e7f61b-4ab5-0dbe-2706-4e11b6079b87 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60505-4089-3 | Trazodone Hydrochloride | 12 in 1 CARTON | TABLET | 12 | 22 | |
| 60505-4089-3 | Trazodone Hydrochloride | 30 in 1 BOTTLE, DISPENSING | TABLET | 30 | 22 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60505-4089-3 | EA - Each | 60505-4089 | c2254ec5-b6ec-4ea7-97da-d6d7e11a5d88 | 1 | 2015-02-02 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| TRAZODONE HYDROCHLORIDE | ACTIVE INGREDIENT | 6E8ZO8LRNM | TRAZODONE HYDROCHLORIDE TABLET [APOTEX CORP] | 8 | |
| TRAZODONE | ACTIVE MOIETY | YBK48BXK30 | TRAZODONE HYDROCHLORIDE TABLET [APOTEX CORP] | 8 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | TRAZODONE HYDROCHLORIDE TABLET [APOTEX CORP] | 8 | |
| COLLOIDAL SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | TRAZODONE HYDROCHLORIDE TABLET [APOTEX CORP] | 8 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | TRAZODONE HYDROCHLORIDE TABLET [APOTEX CORP] | 8 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | TRAZODONE HYDROCHLORIDE TABLET [APOTEX CORP] | 8 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | TRAZODONE HYDROCHLORIDE TABLET [APOTEX CORP] | 8 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | TRAZODONE HYDROCHLORIDE TABLET [APOTEX CORP] | 8 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 60505-4089 | TRAZODONE HYDROCHLORIDE TABLET [APOTEX CORP] | 20 | Legacy NDC, 2 package rows | 20250322_71961ab1-951d-1493-f76c-2ff25cca2a85.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 856373 | traZODone HCl 100 MG Oral Tablet | PSN | 71961ab1-951d-1493-f76c-2ff25cca2a85 | 22 |
| 856364 | traZODone HCl 150 MG Oral Tablet | PSN | 71961ab1-951d-1493-f76c-2ff25cca2a85 | 22 |
| 856369 | traZODone HCl 300 MG Oral Tablet | PSN | 71961ab1-951d-1493-f76c-2ff25cca2a85 | 22 |
| 856377 | traZODone HCl 50 MG Oral Tablet | PSN | 71961ab1-951d-1493-f76c-2ff25cca2a85 | 22 |
| 856373 | trazodone hydrochloride 100 MG Oral Tablet | SCD | 71961ab1-951d-1493-f76c-2ff25cca2a85 | 22 |
| 856364 | trazodone hydrochloride 150 MG Oral Tablet | SCD | 71961ab1-951d-1493-f76c-2ff25cca2a85 | 22 |
| 856369 | trazodone hydrochloride 300 MG Oral Tablet | SCD | 71961ab1-951d-1493-f76c-2ff25cca2a85 | 22 |
| 856377 | trazodone hydrochloride 50 MG Oral Tablet | SCD | 71961ab1-951d-1493-f76c-2ff25cca2a85 | 22 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 60505-4089-3 | 60505408903 | 12 BOTTLE, DISPENSING in 1 CARTON (60505-4089-3) > 30 TABLET in 1 BOTTLE, DISPENSING | 2014-12-31 | 0000-00-00 | No | No | Current |